Dr. Thomas John Orthmeyer Jr., DO, MBA

Dr. Orthmeyer practices at St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System.

Dr. Orthmeyer's NPI, 1396132098, was assigned on April 20, 2015. Dr. Orthmeyer holds Idaho license O-1193.

Dr. Orthmeyer's primary practice is St. Luke's Nampa Medical Center, at 9850 West St Lukes Drive, Nampa, ID 83687 in Canyon County. The practice phone is (208) 505-2000.

Dr. Orthmeyer's primary practice is St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System. Dr. Orthmeyer is also affiliated with St. Luke's Boise Medical Center. The medical group on file is St. Luke's Health System. Dmand AI also links Dr. Orthmeyer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orthmeyer practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Orthmeyer's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Orthmeyer is licensed in Idaho.

CMS data shows 153 Medicare services from Dr. Orthmeyer across 3 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $10,121 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Orthmeyer in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have anxiety, and 75% have depression. 27% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orthmeyer's median patient age at 52, with 61% women.

In 2024, Dr. Orthmeyer wrote 2,701 Medicare Part D claims for 205 patients. 95% of them were for generic drugs. CMS names the drug for 2,453 of them, across 50 drugs with 11 or more claims each, at $231,272 in total drug cost. In 2023, CMS named 2,012 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Orthmeyer for performance year 2024, reported as part of a group. Dr. Orthmeyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orthmeyer as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Orthmeyer from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $16.